The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
| Autor: | Cleland, John GF, Teerlink, John R, Senior, Roxy, Nifontov, Evgeny M, Mc Murray, John JV, Lang, Chim C, Tsyrlin, Vitaly A, Greenberg, Barry H, Mayet, Jamil, Francis, Darrel P, Shaburishvili, Tamaz, Monaghan, Mark, Saltzberg, Mitchell, Neyses, Ludwig, Wasserman, Scott M, Lee, Jacqueline H, Saikali, Khalil G, Clarke, Cyril P, Goldman, Jonathan H, Wolff, Andrew A, Malik, Fady I |
|---|---|
| Zdroj: | In The Lancet 2011 378(9792):676-683 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|